标题/作者	年份
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade G Morad, BA Helmink, P Sharma, JA Wargo Cell 184 (21), 5309-5337	2021
Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors–a systematic review and meta-analysis S Hussaini, R Chehade, RG Boldt, J Raphael, P Blanchette, SM Vareki, ... Cancer Treatment Reviews 92, 102134	2021
Investigational biomarkers for checkpoint inhibitor immune-related adverse event prediction and diagnosis MS von Itzstein, S Khan, DE Gerber Clinical chemistry 66 (6), 779-793	2020
The value of 18 F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis N Ayati, R Sadeghi, Z Kiamanesh, ST Lee, SR Zakavi, AM Scott European journal of nuclear medicine and molecular imaging 48, 428-448	2021
Immunotherapy by immune checkpoint inhibitors and nuclear medicine imaging: current and future applications P Decazes, P Bohn Cancers 12 (2), 371	2020
CD8-targeted PET imaging of tumor-infiltrating T cells in patients with Cancer: a phase i first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 Minibody MD Farwell, RF Gamache, H Babazada, MD Hellmann, JJ Harding, ... Journal of Nuclear Medicine 63 (5), 720-726	2022
A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients A Cortellini, S Buti, V Agostinelli, M Bersanelli Seminars in oncology 46 (4-5), 362-371	2019
PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions M Unterrainer, M Ruzicka, MP Fabritius, LM Mittlmeier, M Winkelmann, ... European Radiology Experimental 4, 1-13	2020
Imaging the cancer immune environment and its response to pharmacologic intervention, part 1: the role of 18F-FDG PET/CT A Iravani, RJ Hicks Journal of Nuclear Medicine 61 (7), 943-950	2020
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F] FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0 E Lopci, RJ Hicks, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, ... European journal of nuclear medicine and molecular imaging 49 (7), 2323-2341	2022
FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment A Iravani, MM Osman, AM Weppler, R Wallace, A Galligan, A Lasocki, ... European journal of nuclear medicine and molecular imaging 47, 2776-2786	2020
Decline of programmed death‐1‐positive circulating T regulatory cells predicts more favourable clinical outcome of patients with melanoma under immune checkpoint blockade T Gambichler, U Schröter, S Höxtermann, L Susok, E Stockfleth, ... British Journal of Dermatology 182 (5), 1214-1220	2020
Assessing immune organs on 18 F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients K Prigent, C Lasnon, E Ezine, M Janson, N Coudrais, E Joly, L Césaire, ... European journal of nuclear medicine and molecular imaging 48, 2573-2585	2021
Impact of PET/CT for assessing response to immunotherapy—a clinical perspective D Lang, G Wahl, N Poier, S Graf, D Kiesl, B Lamprecht, M Gabriel Journal of Clinical Medicine 9 (11), 3483	2020
Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers TW Nobashi, Y Nishimoto, Y Kawata, H Yutani, M Nakamura, Y Tsuji, ... The British Journal of Radiology 93 (1115), 20200409	2020
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions C Eze, NS Schmidt-Hegemann, LM Sawicki, J Kirchner, O Roengvoraphoj, ... European journal of nuclear medicine and molecular imaging, 1-15	2021
FDG PET/CT for assessment of immune therapy: opportunities and understanding pitfalls SY Cho, DT Huff, R Jeraj, MR Albertini Seminars in nuclear medicine 50 (6), 518-531	2020
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma M Rosellini, A Marchetti, V Mollica, A Rizzo, M Santoni, F Massari Nature Reviews Urology 20 (3), 133-157	2023
Concurrent Vogt–Koyanagi–Harada disease and impressive response to immune checkpoint blockade in metastatic melanoma T Gambichler, C Seifert, M Lehmann, C Lukas, C Scheel, L Susok Immunotherapy 12 (7), 439-444	2020
Early evaluation of immunotherapy response in lymphoma patients by 18F-FDG PET/CT: a literature overview C Ferrari, N Maggialetti, T Masi, AG Nappi, G Santo, A Niccoli Asabella, ... Journal of Personalized Medicine 11 (3), 217	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。